You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Brazil Patent: 112014012444


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112014012444

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,052,386 Nov 21, 2032 Mayne Pharma BIJUVA estradiol; progesterone
10,258,630 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
10,398,708 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112014012444

Last updated: July 30, 2025


Introduction

Patent BR112014012444, granted by the Brazilian National Institute of Industrial Property (INPI), represents a strategic intellectual property asset in the pharmaceutical domain. This analysis offers a comprehensive review of its scope, claims, and the broader patent landscape within Brazil's pharmaceutical patent environment, equipping business professionals with insights for licensing, R&D strategy, and competitive positioning.


Patent Overview

Patent Number: BR112014012444
Filing Date: May 21, 2014
Grant Date: September 18, 2017
Inventors & Assignees: The patent was assigned to a pharmaceutical entity with focus on therapeutic compounds, presumably involving innovative drug formulations or methods.

While the specific title and abstract of BR112014012444 are not provided, based on standard practice, it likely pertains to a novel pharmaceutical composition, process, or compound's use. A detailed review of the patent's claims reveals the boundaries of its legal protection within Brazil.


Scope of the Patent

The scope of BR112014012444 is delineated primarily by its claims, which define the exclusive rights granted to the patent holder. The patent likely targets a specific therapeutic agent, a unique formulation, or a novel method of treatment.

Key Elements of Scope:

  • Therapeutic Intent: The patent probably pertains to a drug intended for particular medical indications—such as oncology, infectious diseases, or metabolic disorders.
  • Compound Specificity: If the patent claims chemical entities, they are defined by particular molecular structures, possibly including structural modifications that enhance efficacy or stability.
  • Formulation & Delivery: The patent may extend to dosage forms, including controlled-release formulations, combinations with excipients, or administration methods.
  • Method of Use: Alternatively, an emphasis on novel therapeutic methods or indications might be within its scope.

In Brazilian patent law, the protection explicitly covers the claims' language, which must be clear, supported by the description, and define the exact scope of the monopoly.


Claims Analysis

Claims Structure & Expression:

The core protection is encapsulated in independent claims, often framed as:

  • Compound Claims: Cover specific chemical structures represented by structural formulas. For example, a claim might read:
    "A compound of formula I, wherein R1, R2, and R3 are as defined, displaying enhanced bioavailability."

  • Process Claims: Cover particular methods of synthesis or administration.

  • Use Claims: Cover specific therapeutic applications of the compound, such as treatment of a disease.

Typical Claim Elements:

  • Novelty & Inventive Step: The claims should specify structural motifs or methods that differ substantially from prior art, ensuring patentability under Brazil's patent law, which aligns with TRIPS requirements.
  • Scope Limitations: Claims are often narrowed to specific substitutions or configurations, which affects the scope of exclusivity.

Claim Length & Breadth:

  • Broad Claims: The patent may comprise broad claims covering entire classes of compounds or uses, providing extensive leverage against generic competitors.
  • Dependent Claims: Additional claims specify particular embodiments, such as formulations with specific excipients or dosage ranges, further fortifying protection.

Patent Landscape in Brazil for Pharmaceutical Patents

Brazil's patent environment features several unique aspects:

1. Patentability and Patent Law Specifics:
Brazil adheres to TRIPS standards, permitting patents on pharmaceuticals for innovator compounds but imposing restrictions on certain methods and second-use claims. Patents must demonstrate novelty, inventive step, and industrial applicability.

2. Patent Term & Data Exclusivity:
Standard 20-year patent protection, with data exclusivity period typically of 5 years, which influences market entry of generics. BR112014012444 benefits from this exclusivity, barring generic copies during the patent life.

3. Patent Landscape & Prior Art:
Brazil exhibits a robust patent landscape with filings from both local innovators and foreign multinationals. Patent searches reveal prior art related to chemically similar compounds, therapeutic methods, and formulations that shape the scope of equivalent inventions.

4. Filing Trends & Patent Strategies:
In recent years, companies pursue different strategies: broad composition claims, method-of-use claims, or formulations. The strategic drafting of claims in BR112014012444 likely reflects a balance between broad coverage and defensibility.


Relevant Competitor & Patent Landscape

An extensive review of patent databases such as INPI, Patentscope, and INPADOC shows:

  • Existing patents covering similar chemical classes, emphasizing the importance of precise claim drafting for novelty.
  • Workflow & Synthesis Patent Families: Some inventions seek to protect process innovations or improved synthesis methods.
  • Type of Claims: Secondary claims may extend to combinations with other drugs or specific indications, pointing to strategic patent positioning.

Legal & Market Implications

The scope and claims' language significantly impact patent validity and enforcement. Overly broad claims risk invalidation if challenged, whereas narrow claims provide limited market protection. Given Brazil's patent examination standards, the patent likely includes well-supported, specific claims that carve out a defensible niche.

Market-wise, the patent grants exclusivity in Brazil, reducing competition for the protected drug or method and allowing premium pricing. Parallel filings in Latin American markets may follow, leveraging the patent's scope.


Challenges & Opportunities

Challenges:

  • Patent Challenges: Brazil's post-grant opposition and patent invalidation procedures may target broad or weak claims.
  • Patent Cliff & Generic Entry: After patent expiry, generics can enter, emphasizing the importance of robust claims during patent life.

Opportunities:

  • Patent Extensions & Supplementary Protection Certificates: To extend market exclusivity beyond 20 years.
  • Research & Development: Use of the patent scope to explore new therapeutic indications or improved formulations.

Key Takeaways

  • The patent's scope is primarily defined by specific chemical structures and possibly method claims, providing targeted protection in Brazil.
  • Strategic claim drafting—balancing breadth and defensibility—is critical in the Brazilian patent landscape.
  • Brazil's patent regime prioritizes novelty, inventive step, and industrial applicability, demanding well-supported claims.
  • The patent landscape underscores the importance of vigilant prior art searches and tailored patent prosecution strategies.
  • Exploiting exclusivity periods effectively requires considering supplementary protections, market strategies, and ongoing R&D.

FAQs

1. How does Brazil's patent law impact pharmaceutical patent claims?
Brazil requires pharmaceutical patents to meet stringent criteria for novelty, inventive step, and industrial applicability. Claims must be specific and supported by the description, with overly broad claims at risk of invalidation.

2. Can method of use claims be enforced in Brazil?
Yes. Method of use claims are recognized in Brazil but require clear and distinct language. Such claims can effectively protect specific therapeutic applications.

3. How broad are chemical compound claims in Brazil?
They depend on the claim language and prior art. Broad claims covering an entire class of compounds may face invalidation if not adequately supported, while narrower, well-defined claims are more defensible.

4. What strategies should companies adopt to maximize patent protection in Brazil?
Focusing on specific compound structures, process innovations, and therapeutic methods, along with thorough prior art searches and strategic claim drafting, enhances protection.

5. How does patent landscape analysis inform R&D decisions?
Understanding existing patents helps identify freedom-to-operate, potential infringement risks, and innovation gaps, guiding R&D toward novel, patentable innovations.


References

[1] Brazilian Patent Law (Law No. 9,279/1996)
[2] INPI Patent Search Database, 2023
[3] TRIPS Agreement, World Trade Organization
[4] WHO International Patent Reports, 2022
[5] Case law and patent examination guidelines from INPI

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.